Ca2+-binding protein S100A11: A novel diagnostic marker for breast carcinoma

29Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

To evaluate whether S100A11 could be considered to be a novel diagnostic marker in breast carcinoma, the method of differential proteomics, Western blotting, and immunohistochemistry were used to detect the expression pattern and subcellular localization of S100A11. Statistical analyses indicated that specific up-regulated of A100A11 did not correlate with other prognostic factors such as age, tumor size, grade and stage, ER, PR, HER-2 and nodal status. Our data support that S100A11 is a novel diagnostic marker in breast carcinoma. Analysis of S100A11 expression in breast cancer may be an effective tool help in detection of early-stage breast cancer.

Cite

CITATION STYLE

APA

Liu, X. G., Wang, X. P., Li, W. F., Yang, S., Zhou, X., Li, S. J., … Fan, Z. M. (2010). Ca2+-binding protein S100A11: A novel diagnostic marker for breast carcinoma. Oncology Reports, 23(5), 1301–1308. https://doi.org/10.3892/or_00000764

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free